THE endomorphins are potent and selective endogenous agonists at the mu opioid receptor. We describe here the postnatal ontogeny of endomorphin-2 like immunoreactivity (EM2-LI) in the dorsal horn of the rat medulla and spinal cord. EM2-LI is dense in the super®cial lamina of the dorsal horn of the adolescent and adult rat, with ®bers also present in skin and dorsal root ganglia. No staining was noted at 3 days of age or younger. Faint and limited staining was noted by 7 days of age. The density and distribution of the immunoreactivity increased with age, reaching an adult-like distribution by weaning. Stress-induced responses mediated by endogenous opioids occur late in development and may be related to the late appearance of endomorphin-2.
Introduction
Endomorphins are endogenous ligands for the mu opioid receptor that were recently isolated from the human [1] and bovine [2] central nervous system. Endomorphin 1 (EM-1; Tyr-Pro-Trp-Phe-NH 2 ) is localized throughout the brain and spinal cord [3] . Endomorphin-2 (EM-2; Tyr-Pro-Phe-Phe-NH 2 ) is densely localized in primary afferents, super®cial lamina of the dorsal horn of the spinal cord, and in the trigeminal tract and trigeminal nucleus of the brain stem [3±7] , with ®bers found in many other sites throughout the brain. EM-2 is probably synthesized in the dorsal root ganglia neurons and transported to super®cial lamina of the spinal cord [5, 6] . Endomorphins are analgesic, acting through mu opioid receptors [2,8±12] . Taken together, these data suggest that endomorphins are the major endogenous opioid ligands for pre-and postsynaptic spinal mu opioid receptors, and could be critical regulators of a variety of physiological functions.
Opioid-mediated behaviors develop at different ages (see [13] for review). Mu opioid receptors develop early in the rat and mu opiates [14±16] are analgesic in neonates (see [17, 18] for reviews). In contrast, stress-induced analgesias, dependent on release of opioid peptides, develop later [19±23] . This latter maturation may be due to differential development of these peptides. Because of the localization of endomorphin-2 in the dorsal horn of the spinal cord and trigeminal nucleus in the adult [3, 4] , we used the previously characterized antibodies to this peptide and examined its distribution in the spinal cord and hindbrain of infant rats using standard immunocytochemical methods.
Materials and Methods
Research protocols were approved by the Institutional Animal Care and Use Committee and were conducted under the ethical guidelines of the International Association for the Study of Pain, the Society for Neuroscience and the Society for Developmental Psychobiology.
Long Evans hooded rats aged 0, 3, 7, 10±11, 14 and 35±44 days of age bred at New York State Psychiatric Institute were subjects in this study. Housing conditions followed standard methods. Cages were checked daily at $10.00 h and 17.00 h. Pups found on that day at either time were termed 0 days of age. Pups were deeply anesthetized, and perfused with acrolein/paraformaldehyde [3±5]. Immunocytochemical methods, using a previously characterized antibody to EM-2, were performed on oating 30 ìm sections as described previously [3± 5]. Most dilutions of the primary antibody were at 1:5000. Homologous preabsorption with 0.01± 100 ìM of the parent peptide blocked staining. There was some heterologous blocking of staining by the endomorphin-1 peptide, but it occurred at concentrations 1±2 orders of magnitude greater than that for homologous blockade. The standard ABC method was used with diaminobenzidine as the chromogen [24] . Tissue from young animals was assayed with tissue from older animals to ensure that negative results were not likely to be due to assay error. Furthermore, tissues from a single age were assayed at different times, often separated by several weeks.
Results
Spinal cord: We examined the cervical and lumbar dorsal horn: results were the same at both levels. In the adolescent rat (35±44 days of age) the previously described adult pattern of staining was observed [ 3± 7] . Staining was limited largely to a dense plexus in the super®cial laminae of the dorsal horn (lamina I and IIo) with a limited number of ®bers penetrating ventrally (Fig. 1) . In contrast, no staining was seen at 0 and 3 days of age. Staining was noted by 7 days of age and increased in density with increasing age (Fig. 2) . Although staining was present at 7 days, the pattern of staining was not mature. For example, the immunoreactivity was limited to the medial aspects of the dorsal horn, and the density of the stain was generally lighter (Fig. 2) . The density and distribution of EM2-LI increased gradually with age, and although still immature at 14 days of age they became similar to the adult pattern by 21 days of age.
To compare the maturation of EM2-LI in the spinal cord with that of other opioid peptides, we performed a limited number of experiments in 3- day-old pups with antibodies to enkephalin and dynorphin [1±8] . Both enkephalin-and dynorphinlike immunoreactivity were present at 3 days of age in the super®cial dorsal horn of the lumbar cord (data not shown).
Medulla: A similar pattern was noted in the dorsal horn of the medulla (adult distribution shown in Fig. 3) . Staining was totally absent at 0 and 3 days of age, ®rst appearing in an immature form at 7 days (Fig. 4) , and reaching the adult-like distribution and density by 21 days of age.
Skin and dorsal roots:
We noted a limited number of ®ne ®bers in the skin and dorsal root ganglia of the adolescent rat (35±44 days; Fig. 5 ). We were unable to identify ®bers in these tissues in preweaning pups.
Discussion
Endomorphin-2 is distributed in the super®cial aspects of the spinal and medullary dorsal horn. It matures relatively late compared to other opioid peptides and receptors. Endomorphin-2 is strategically localized to be involved in the modulation of noxious input. It is analgesic itself when injected intrathecally [1, 8, 11] , and may mediate stress-induced analgesias. Of note, we have found that endomorphin-1, the sibling mu opioid speci®c en- dogenous tetrapeptide [1] , also develops relatively late [25] . DRG neurons have both central and peripheral branches, and EM2-LI should appear in both branches. This study provides the ®rst evidence for EM2-LI in peripheral ®bers that innervate the skin. We were unable to detect these ®bers until adolescence. However, unlike the more abundant substance P and CGRP ®bers, which we have been able to stain in infant rats (unpublished results), EM2-LI ®bers are very ®ne and sparse, even in the older animals. It is therefore unclear whether they are absent or below detectability in the young animals.
The relatively late appearance of the EM2-LI would imply that the peptide is not involved in early opioid-mediated events. There is ample evidence that exogenous opiates, acting on receptors that develop earlier than endogenous peptides [14±16], can affect developing animals during gestation and the postnatal period. However, we know of no evidence for stress-induced responses that require activation of endogenous opioids, before 5 days of age. Spear and colleagues described a naloxonereversible analgesia in 5-day-old rat pups induced by long-term (30 min) isolation from the dam, siblings and nest. There was no evidence of analgesia following 10 min of similar isolation [21] . By 10 days of age, however, even short-term isolation induces a naloxone-reversible analgesia [23, 26] . Neither of the studies used speci®c receptor antagonists and thus it is not known whether mu opioid receptors are involved. At 10 and 14 days of age the presence of an unfamiliar male, which in the natural setting presents a danger to rat pups, induces a strong analgesia that is blocked by naltrexone and the mu opioid speci®c antagonist CTOP [19, 20] . The strange male does not induce analgesia in 7-day-old pups. Although a variety of developmental factors may be involved, these ®ndings of relatively late onset of endogenous opioid-mediated responses are consistent with the developmental course of EM2-LI.
Conclusion
Endomorphin-2 is present in regions of the medulla and spinal cord that are involved in the processing of pain. The adult-like distribution of endormorphin-2 is present by 21 days of age, but is not detectable at 3 days of age and younger. The development to the adult pattern is slow over the following 2 weeks. Thus endomorphin-2, like endomorphin-1, but unlike other opioid peptides develops rather late and may explain the delayed appearance of behaviors mediated by endogenous opioids.
